RxDoctor Payments Data

Douglas Smith

Primary Podiatric Medicine · Raleigh, NCNPI 1669440798

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations.

$2,283in general payments, 2019–2025

Across 53 payments — averaging $43.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$436
  • Amgen$380
  • AbbVie$223
  • Smith+Nephew$193
  • Nevro Corp.$156
  • Lifenet Health$149
  • plus $744 from 16 others

What the payments were for

  • Food & beverage$2,283100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,283 in reported general payments places this provider in the 65th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$156,061
Medicare patients
573
Services billed
2,544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole92$2,032
Gabapentin113$1,463
Ciclopirox24$826
Naproxen121$753
Colchicine15$571
Mupirocin66$533
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav42$334
Terbinafine Hcl19$317
Pregabalin29$281
Cefadroxil33$278
Methylprednisolone31$192
Nystatin17$143
Clindamycin Hcl13$117
Meloxicam22$94
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$79

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →